Rockwell Medical, Inc. (RMTI) Stock Analysis

Company Overview

The market values Rockwell Medical, Inc. (RMTI) at $32.18M. The company sits in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. The company reports 157 employees.

Over the past 52 weeks the price has ranged from $4.89 to $18.50. The most recent close on file for RMTI is $7.99, dated September 4, 2026. The close was unchanged from the previous session. The latest close sits 63.39% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $69.26M. That is −31.76% against the prior fiscal year, when revenue was $101.49M. The same year closed with a net loss of $5.31M. The reported profit margin is −7.33%. That is 4.2 percentage points below the Drug Manufacturers - Specialty & Generic median of −3.14%. Earnings per share on a trailing basis come to −1.32.

Across the 4 fiscal years on file, revenue moves from $72.81M in 2022 to $69.26M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 114.07. The PEG ratio, which sets the P/E against expected earnings growth, reads 4.43. Measured against sales, the shares trade at 0.46 times revenue. On price-to-sales that is 0.2 times the Drug Manufacturers - Specialty & Generic median of 2.3. The medians here are taken across 103 Drug Manufacturers - Specialty & Generic companies that report the metric.

The reported beta is 1.64. Daily returns over the trailing 10 years annualize to a volatility of 81.85%. The trailing one-year price return is −52.44%. Across 10 years the annualized return works out at −36.86%.

Growth & Income

No dividend is on file for RMTI.

The strongest complete calendar year on file is 2023 at +87.13%; the weakest is 2022 at −77.61%. Of the 9 complete calendar years on file, 3 finished higher. 2026 is still running; the price is −3.73% year to date.